title: The immunogenicity of humanized and fully human antibodies: residual immunogenicity resides in the CDR regions.
abstract: Monoclonal antibodies represent an attractive therapeutic tool as they are highly specific for their targets, convey effector functions and enjoy robust manufacturing procedures. Humanization of murine monoclonal antibodies has vastly improved their in vivo tolerability. Humanization, the replacement of mouse constant regions and V framework regions for human sequences, results in a significantly less immunogenic product. However, some humanized and even fully human sequence-derived antibody molecules still carry immunological risk. To more fully understand the immunologic potential of humanized and human antibodies, we analyzed CD4(+) helper T cell epitopes in a set of eight humanized antibodies. The antibodies studied represented a number of different VH and VL family members carrying unique CDR regions. In spite of these differences, CD4(+) T cell epitopes were found only in CDR-sequence containing regions. We were able to incorporate up to two amino acid modifications in a single epitope that reduced the immunogenic potential while retaining full biologic function. We propose that immunogenicity will always be present in some antibody molecules due to the nature of the antigen-specific combining sites. A consequence of this result is modifications to reduce immunogenicity will be centered on the affinity-determining regions. Modifications to CDR regions can be designed that reduce the immunogenic potential while maintaining the bioactivity of the antibody molecule.
authors.affiliation: Facet Biotech, Redwood City, CA, USA. fiona.harding@facetbiotech.com
authors.forename: Fiona A
authors.initials: FA
authors.lastname: Harding
authors.forename: Marcia M
authors.initials: MM
authors.lastname: Stickler
authors.forename: Jennifer
authors.initials: J
authors.lastname: Razo
authors.forename: Robert B
authors.initials: RB
authors.lastname: DuBridge
mesh_terms: D000818:Animals; D000911:Antibodies, Monoclonal / Q000737:chemistry / Q000276:immunology*; D000915:Antibody Affinity; D000918:Antibody Specificity; D002478:Cells, Cultured; D022801:Complementarity Determining Regions / Q000235:genetics / Q000276:immunology*; D018984:Epitopes, T-Lymphocyte / Q000235:genetics / Q000276:immunology; D006801:Humans; D051379:Mice; D015202:Protein Engineering; D006377:T-Lymphocytes, Helper-Inducer / Q000276:immunology
chemical_list: D000911:Antibodies, Monoclonal; D022801:Complementarity Determining Regions; D018984:Epitopes, T-Lymphocyte
references.citation: Nat Rev Immunol. 2005 Nov;5(11):853-65
references.pmid: 16261173
references.citation: Methods. 2005 May;36(1):3-10
references.pmid: 15848070
references.citation: J Clin Invest. 2004 May;113(10):1498-510
references.pmid: 15146248
references.citation: Immunol Cell Biol. 2008 Feb;86(2):146-52
references.pmid: 18227854
references.citation: J Clin Invest. 1998 Jul 1;102(1):215-22
references.pmid: 9649575
references.citation: Transplantation. 2006 Feb 15;81(3):308-15
references.pmid: 16477212
references.citation: Toxicology. 1995 Dec 20;105(1):23-9
references.pmid: 8638282
references.citation: Semin Hematol. 2004 Jan;41(1 Suppl 1):82-8
references.pmid: 14872427
references.citation: J Exp Med. 2004 Oct 4;200(7):847-56
references.pmid: 15466619
references.citation: Nat Rev Immunol. 2008 Jul;8(7):523-32
references.pmid: 18566595
references.citation: Aliment Pharmacol Ther. 2008 Nov 1;28(9):1122-6
references.pmid: 18691349
references.citation: Curr Opin Immunol. 1998 Apr;10(2):208-13
references.pmid: 9602310
references.citation: Biotechnol Annu Rev. 2008;14:191-202
references.pmid: 18606364
references.citation: Curr Opin Pharmacol. 2008 Oct;8(5):620-6
references.pmid: 18775515
references.citation: J Exp Med. 2009 Aug 3;206(8):1643-6
references.pmid: 19635860
references.citation: J Immunol. 2004 Jun 15;172(12):7476-84
references.pmid: 15187126
references.citation: J Immunol. 1990 Jun 1;144(11):4256-61
references.pmid: 2341720
references.citation: Cell. 1998 Dec 23;95(7):875-8
references.pmid: 9875841
references.citation: Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9205-10
references.pmid: 15197260
references.citation: Genes Immun. 2004 Jan;5(1):1-7
references.pmid: 14735143
references.citation: J Immunol. 1987 Oct 15;139(8):2825-33
references.pmid: 3498771
references.citation: Nat Biotechnol. 2005 Sep;23(9):1105-16
references.pmid: 16151404
references.citation: J Immunol. 2005 Aug 15;175(4):2391-400
references.pmid: 16081810
references.citation: Rheumatol Int. 2007 Jan;27(3):269-74
references.pmid: 17006705
references.citation: Curr Opin Immunol. 2009 Jun;21(3):266-73
references.pmid: 19502021
references.citation: Proc Natl Acad Sci U S A. 2008 Apr 8;105(14):5471-6
references.pmid: 18367670
references.citation: Ann Oncol. 2008 Jan;19(1):92-8
references.pmid: 17785764
references.citation: J Immunol. 1996 Aug 1;157(3):1037-46
references.pmid: 8757607
references.citation: Scand J Immunol. 2009 Dec;70(6):526-30
references.pmid: 19906193
references.citation: Ann Rheum Dis. 2009 Nov;68(11):1739-45
references.pmid: 19019895
references.citation: Transplantation. 1990 Apr;49(4):697-702
references.pmid: 2109379
references.citation: Drug Discov Today. 2004 Jan 15;9(2):82-90
references.pmid: 15012932
references.citation: Arthritis Rheum. 2008 Nov;58(11):3402-12
references.pmid: 18975305
references.citation: Methods. 2005 May;36(1):69-83
references.pmid: 15848076
references.citation: Dev Biol (Basel). 2003;112:15-21
references.pmid: 12762500
references.citation: Clin Exp Immunol. 2002 Jul;129(1):169-76
references.pmid: 12100037
references.citation: Anal Biochem. 1997 Apr 5;247(1):102-10
references.pmid: 9126378
references.citation: Annu Rev Immunol. 2006;24:541-70
references.pmid: 16551259
references.citation: N Engl J Med. 2008 Mar 13;358(11):1109-17
references.pmid: 18337601
references.citation: J Immunother. 2000 Nov-Dec;23(6):654-60
references.pmid: 11186153
references.citation: Curr Med Chem. 2002 Dec;9(24):2191-9
references.pmid: 12470241
references.citation: Immunol Rev. 2004 Aug;200:182-96
references.pmid: 15242405
references.citation: Trends Immunol. 2002 Nov;23(11):526-9
references.pmid: 12401404
references.citation: Curr Opin Drug Discov Devel. 2007 Mar;10(2):219-27
references.pmid: 17436557
references.citation: AAPS J. 2006 Aug 04;8(3):E501-7
references.pmid: 17025268
references.citation: Thymus. 1994;22(3):141-52
references.pmid: 7940642
references.citation: Rheumatology (Oxford). 2008 May;47(5):567-71
references.pmid: 18316337
references.citation: Annu Rev Immunol. 2007;25:21-50
references.pmid: 17029568
references.citation: Nat Biotechnol. 2007 Oct;25(10):1134-43
references.pmid: 17921999
references.citation: Blood. 2008 Mar 1;111(5):2725-32
references.pmid: 18156498
references.citation: Curr Opin Immunol. 2008 Aug;20(4):450-9
references.pmid: 18606226
references.citation: J Neuroimmunol. 2009 Jul 25;212(1-2):65-73
references.pmid: 19477024
references.citation: Adv Immunol. 2007;95:83-110
references.pmid: 17869611
references.citation: J Immunol Methods. 1999 Dec 10;231(1-2):11-23
references.pmid: 10648924
references.citation: Curr Opin Mol Ther. 2003 Apr;5(2):172-9
references.pmid: 12772508
references.citation: Jpn J Clin Oncol. 2009 May;39(5):321-6
references.pmid: 19287023
references.citation: Nat Immunol. 2000 Dec;1(6):453-5
references.pmid: 11101860
references.citation: Blood Rev. 2009 May;23(3):137-42
references.pmid: 18951668
references.citation: Dev Biol (Basel). 2003;112:55-9
references.pmid: 12762504
references.citation: Nat Biotechnol. 2005 Sep;23(9):1117-25
references.pmid: 16151405
references.citation: Clin Exp Immunol. 2004 Sep;137(3):496-502
references.pmid: 15320898
references.citation: J Immunol Methods. 2003 Oct 1;281(1-2):95-108
references.pmid: 14580884
references.citation: Clin Cancer Res. 2003 Apr;9(4):1347-53
references.pmid: 12684403
references.citation: J Immunol. 2005 Aug 15;175(4):2184-90
references.pmid: 16081785
references.citation: Immunity. 2009 May;30(5):646-55
references.pmid: 19464987
references.citation: Cancer Res. 2001 Sep 15;61(18):6851-9
references.pmid: 11559561
references.citation: Transfusion. 2006 Sep;46(9):1526-36
references.pmid: 16965580
references.citation: Vaccine. 2009 Dec 10;28(1):14-20
references.pmid: 19818425
references.citation: J Immunol. 2007 Jun 1;178(11):7467-72
references.pmid: 17513798
references.citation: Immunotechnology. 1997 Mar;3(1):31-43
references.pmid: 9154466
references.citation: Annu Rev Immunol. 2001;19:23-45
references.pmid: 11244029
references.citation: Ann N Y Acad Sci. 1995 Sep 29;764:242-60
references.pmid: 7486531
references.citation: Nature. 1994 Apr 28;368(6474):856-9
references.pmid: 8159246
references.citation: Ann Rheum Dis. 2006 Sep;65(9):1249-50
references.pmid: 16905585
references.citation: Int Immunol. 2007 Jul;19(7):857-65
references.pmid: 17576752
references.citation: Semin Thromb Hemost. 2000;26(2):151-5
references.pmid: 10919407
references.citation: Mol Cancer Ther. 2005 Nov;4(11):1791-800
references.pmid: 16276001
references.citation: Nat Rev Immunol. 2009 Dec;9(12):833-44
references.pmid: 19935803
references.citation: N Engl J Med. 1992 Oct 22;327(17):1209-15
references.pmid: 1406793
references.citation: J Mol Recognit. 2003 Sep-Oct;16(5):299-317
references.pmid: 14523943
references.citation: Autoimmunity. 2007 Mar;40(2):131-7
references.pmid: 17453712
references.citation: Neurol Sci. 2002 Apr;23 Suppl 1:S1-8
references.pmid: 12032582
references.citation: Clin Exp Rheumatol. 1999 Nov-Dec;17(6 Suppl 18):S73-7
references.pmid: 10589362
references.citation: Haematologica. 2000 Oct;85(10 Suppl):2-5; discussion 5-6
references.pmid: 11187864
references.citation: IDrugs. 2009 Apr;12(4):233-7
references.pmid: 19350467
references.citation: Ann Immunol (Paris). 1974 Jan;125C(1-2):373-89
references.pmid: 4142565
references.citation: Curr Opin Biotechnol. 2009 Dec;20(6):708-14
references.pmid: 19880308
references.citation: Scand J Immunol. 1999 Sep;50(3):296-301
references.pmid: 10447939
references.citation: Arthritis Rheum. 2008 Apr;58(4):964-75
references.pmid: 18383539
references.citation: Dev Biol (Basel). 2003;112:37-53
references.pmid: 12762503
references.citation: Clin Exp Immunol. 2008 Apr;152(1):138-46
references.pmid: 18307520